Clinical Trials

51 results for Bladder Cancer


A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants With Muscle-invasive Bladder Cancer (KEYNOTE-B15 / EV-304)

  • Condition: Muscle Invasive Bladder Cancer
  • Study ID: NCT04700124
View Trial